Tenapanor with phosphate binders for high phosphorus in hemodialysis
This study tests whether adding a new medicine (tenapanor) to your current phosphate binder can help lower your blood phosphorus levels more effectively. You must be on hemodialysis and already taking a phosphate binder, and have high phosphorus levels.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been on regular hemodialysis for at least 3 months (3 times a week, 4 hours per session).
- You have been taking a phosphate binder for at least 3 weeks at a stable dose.
- Your latest blood phosphorus level is above 4.5 mg/dL.
- You have not had diarrhea within the last week.
- You do not have inflammatory bowel disease or irritable bowel syndrome with diarrhea.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a new medicine called TS-172 can help lower phosphorus levels in patients on peritoneal dialysis (a type of kidney treatment). High phosphorus can cause bone problems and other complications, so the trial aims to see if this drug works better than current treatments.
This trial tests a new drug called AP301 to lower high phosphate levels in people on dialysis. It's designed to help control phosphate, which can be hard to manage with diet and current medications.
This trial tests a new medication called AP306 for people on hemodialysis who have high blood phosphate. It aims to see if the drug is safe, tolerable, and helps lower phosphate levels.
This trial tests a new medicine called TS-172 for people with high phosphorus levels who are on hemodialysis. It aims to lower phosphorus levels and is taken along with your current phosphate binder medication.
This study tests a new medication called TS-172 for people on dialysis whose phosphorus levels stay high despite taking other phosphorus-lowering drugs. The goal is to see if TS-172 can better control phosphorus and help prevent bone and heart problems that high phosphorus causes.
This study tests an investigational drug called tenapanor for people with chronic idiopathic constipation (constipation with no clear cause). It aims to see if the drug can safely improve bowel movements in adults.
Hear when a new CKD 5D, Hemodialysis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.